Cargando…
An α(2)-adrenoceptor agonist: Dexmedetomidine induces protective cardiomyocyte hypertrophy through mitochondrial-AMPK pathway
Aims: Dexmedetomidine (Dex) as a highly selective α(2)-adrenoceptor agonist, was widely used anesthetic in perioperative settings, whether Dex induces cardiac hypertrophy during perioperative administration is unknown. Methods: The effects of Dex on cardiac hypertrophy were explored using the transv...
Autores principales: | Weng, Xiaojian, Liu, Hua, Zhang, Xiaodan, Sun, Qianqian, Li, Cheng, Gu, Minglu, Xu, Yanyifang, Li, Shitong, Li, Weiwei, Du, Jianer |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7532472/ https://www.ncbi.nlm.nih.gov/pubmed/33029088 http://dx.doi.org/10.7150/ijms.47598 |
Ejemplares similares
-
Effects of alpha 2-adrenoceptor agonists dexmedetomidine and guanfacine on morphine analgesia and tolerance in rats
por: Gursoy, Sinan, et al.
Publicado: (2011) -
Testosterone activates glucose metabolism through AMPK and androgen signaling in cardiomyocyte hypertrophy
por: Troncoso, Mayarling Francisca, et al.
Publicado: (2021) -
Crosstalk between AMPK activation and angiotensin II-induced hypertrophy in cardiomyocytes: the role of mitochondria
por: Hernández, Jessica Soto, et al.
Publicado: (2014) -
The α(2) Adrenoceptor Agonist and Sedative/Anaesthetic Dexmedetomidine Excites Diverse Neuronal Types in the Ventrolateral Preoptic Area of Male Mice
por: Fan, Sumei, et al.
Publicado: (2023) -
Dexmedetomidine attenuates sevoflurane-induced neurocognitive impairment through α2-adrenoceptors
por: Zhang, Yufeng, et al.
Publicado: (2021)